At Vivani we are developing our novel NanoPortal™ implant technology for delivering the intended dose of medication steadily over extended periods of time. It has been engineered with the goal of avoiding challenges that may be associated with fluctuating drug delivery.

2 days ago · Vivani’s lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in obese or overweight individuals. Vivani’s emerging pipeline includes NPM-139 (semaglutide implant) which is also under development for chronic weight management.

1 day ago · ALAMEDA, Calif., March 13, 2025--Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants ...

1 day ago · About Vivani Medical, Inc. Leveraging its proprietary NanoPortal TM platform, Vivani develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Vivani’s lead program, NPM-115, is a six ...

Sep 25, 2024 · Vivani Medical is an emerging biopharmaceutical company developing a pipeline of miniature, long-term drug implants with its proprietary NanoPortal™ platform technology for obesity/weight management and other chronic diseases.

2 days ago · ALAMEDA, Calif., March 12, 2025--Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants ...

2 days ago · The share price of Nasdaq-listed Vivani rose by 1.8% at market open compared to a pre-announcement market close yesterday [11 March]. Investor reaction to the company, which has a market cap of ...

1 day ago · To learn more about Vivani or LIBERATE-1, the upcoming First-in-Human trial of our long-term GLP-1 implant, please fill out the form. Name Phone Email Reason for contact. Message. By providing a telephone number and submitting the form you are consenting to be contacted by SMS text message. ...

Vivani™ is an innovative, near-clinical stage biopharmaceutical company. Leveraging our proprietary NanoPortal™ platform technology, we are developing a portfolio of miniature, long-term drug implants to address two main barriers of optimal chronic disease treatment: medication non-adherence and tolerability.

1 day ago · Vivani Medical announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial.This milestone marks a critical step toward addressing one of ...